Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

MariMed Q1 Sales $37.933M Beat $36.950M Estimate

Author: Benzinga Newsdesk | May 08, 2024 05:25pm
MariMed (OTC:MRMD) reported quarterly sales of $37.933 million which beat the analyst consensus estimate of $36.950 million by 2.66 percent. This is a 10.33 percent increase over sales of $34.380 million the same period last year.

Posted In: MRMD


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist